Phase 1 study of PSMA ADC, an antibody‐drug conjugate targeting prostate‐specific membrane antigen, in chemotherapy‐refractory prostate cancer von Petrylak, Daniel P., Kantoff, Philip, Vogelzang, Nicholas J., Mega, Anthony, Fleming, Mark T., Stephenson, Joe J., Frank, Richard, Shore, Neal D., Dreicer, Robert, McClay, Edward F., Berry, William R., Agarwal, Manish, DiPippo, Vincent A., Rotshteyn, Yakov, Stambler, Nancy, Olson, William C., Morris, Stephen A., Israel, Robert J.

Volltext

Randomized phase II trial of autologous dendritic cell vaccines versus autologous tumor cell vaccines in metastatic melanoma: 5-year follow up and additional analyses von Dillman, Robert O, Cornforth, Andrew N, Nistor, Gabriel I, McClay, Edward F, Amatruda, Thomas T, Depriest, Carol

Volltext

Efficacy and safety of first-line avelumab in patients with advanced non-small cell lung cancer: results from a phase Ib cohort of the JAVELIN Solid Tumor study von Verschraegen, Claire F, Jerusalem, Guy, McClay, Edward F, Iannotti, Nicholas, Redfern, Charles H, Bennouna, Jaafar, Chen, Franklin L, Kelly, Karen, Mehnert, Janice, Morris, John C, Taylor, Matthew, Spigel, David, Wang, Ding, Grote, Hans Juergen, Zhou, Dongli, Munshi, Neru, Bajars, Marcis, Gulley, James L

Volltext

Patient-specific dendritic cell vaccines with autologous tumor antigens in 72 patients with metastatic melanoma von Dillman, Robert O, Cornforth, Andrew N, McClay, Edward F, Depriest, Carol

Volltext

Systemic chemotherapy for the treatment of metastatic melanoma von Li, Yan, McClay, Edward F.

Volltext

PSMA ADC monotherapy in patients with progressive metastatic castration‐resistant prostate cancer following abiraterone and/or enzalutamide: Efficacy and safety in open‐label singl... von Petrylak, Daniel P., Vogelzang, Nicholas J., Chatta, Kamal, Fleming, Mark T., Smith, David C., Appleman, Leonard J., Hussain, Arif, Modiano, Manuel, Singh, Parminder, Tagawa, Scott T., Gore, Ira, McClay, Edward F., Mega, Anthony E., Sartor, A. Oliver, Somer, Bradley, Wadlow, Raymond, Shore, Neal D., Olson, William C., Stambler, Nancy, DiPippo, Vincent A., Israel, Robert J.

Volltext

Differences in Clinical Trial Patient Attributes and Outcomes According to Enrollment Setting von LAMONT, Elizabeth B, LANDRUM, Mary Beth, MILLER, Antonius A, CLAMON, Gerald H, ELIAS, Anthony D, MCCLAY, Edward F, VOKES, Everett E, MCNEIL, Barbara J, KEATING, Nancy L, ARCHER, Laura, LAN LAN, STRAUSS, Gary M, LILENBAUM, Rogerio, NIELL, Harvey B, HERBERT MAURER, L, KOSTY, Michael P

Volltext

Tumor Stem Cell Antigens as Consolidative Active Specific Immunotherapy: A Randomized Phase II Trial of Dendritic Cells Versus Tumor Cells in Patients With Metastatic Melanoma von DILLMAN, Robert O, CORNFORTH, Andrew N, DEPRIEST, Carol, MCCLAY, Edward F, AMATRUDA, Thomas T, DE LEON, Cristina, ELLIS, Robin E, MAYORGA, Cheryl, CARBONELL, Denysha, CUBELLIS, James M

Volltext

The Role of Anti-Tumor Necrosis Factor Receptor Agents in Cancer Survivors Revisited von McClay, Edward F

Volltext

Dendritic Versus Tumor Cell Presentation of Autologous Tumor Antigens for Active Specific Immunotherapy in Metastatic Melanoma: Impact on Long-Term Survival by Extent of Disease at... von Dillman, Robert O, McClay, Edward F, Barth, Neil M, Amatruda, Thomas T, Schwartzberg, Lee S, Mahdavi, Khosrow, de Leon, Cristina, Ellis, Robin E, DePriest, Carol

Volltext

Phase II trial of dendritic cells loaded with antigens from self-renewing, proliferating autologous tumor cells as patient-specific antitumor vaccines in patients with metastatic m... von Dillman, Robert O, Selvan, Senthamil R, Schiltz, Patric M, McClay, Edward F, Barth, Neil M, DePriest, Carol, de Leon, Cristina, Mayorga, Cheryl, Cornforth, Andrew N, Allen, Kanoe

Volltext

Completely Regressed Cutaneous Melanocytic Lesion: Was It Benign or Was It Malignant? von Berger, Adam C, McClay, Edward F, Toporcer, Mary, Wolchok, Jedd D, Morris, Gloria J

Volltext

Surgically Unresectable Regional Melanoma Metastases in a Patient With Renal Failure and Peripheral Vascular Disease: Are There Safe and Potentially Effective Treatments? von Feeney, Kendra, Maguire, Henry C, McClay, Edward F, Sato, Takami, Sondak, Vernon K, Toporcer, Mary, Zager, Jonathan S

Volltext

Adjuvant therapy for patients with high-risk malignant melanoma von McClay, Edward F.

Volltext

A phase III trial evaluating the combination of cisplatin, etoposide, and radiation therapy with or without tamoxifen in patients with limited-stage small cell lung cancer: Cancer... von McClay, Edward F, Bogart, Jeff, Herndon, 2nd, James E, Watson, Dee, Evans, Lisa, Seagren, Steven L, Green, Mark R

Volltext

Interruptions of once-daily thoracic radiotherapy do not correlate with outcomes in limited stage small cell lung cancer: Analysis of CALGB phase III trial 9235 von Bogart, Jeffrey A, Watson, Dorothy, McClay, Edward F, Evans, Lisa, Herndon, James E, Laurie, Frances, Seagren, Stephen L, Fitzgerald, T.J, Vokes, Everett, Green, Mark R

Volltext

Introduction: Melanoma: American and European perspectives on diagnosis and treatment von McClay, Edward F., Maio, Michele

Volltext

Abstract CT105: Randomized trial of dendritic vs tumor cell patient-specific vaccines: 5-year analysis von Dillman, Robert O., McClay, Edward F., Amatruda, Thomas T., DePriest, Carol, Carbonell, Denysha J., Cornforth, Andrew N.

Volltext

MODULATION OF CISPLATIN RESISTANCE IN HUMAN-MALIGNANT MELANOMA-CELLS von MCCLAY, EF, ALBRIGHT, KD, JONES, JA, EASTMAN, A, CHRISTEN, R, HOWELL, SB

Volltext

Synergy between tamoxifen and cisplatin in human melanoma cells is dependent on the presence of antiestrogen-binding sites von JONES, J. A, ALBRIGHT, K. D, CHRISTEN, R. D, HOWELL, S. B, MCCLAY, E. F

Volltext